XML 14 R5.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Balance Sheet - USD ($)
$ in Millions
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2019
Assets      
Cash and balances at central banks $ 149,549 $ 139,258 $ 107,068
Loans and advances to banks 15,633 16,972 12,447
Receivables from securities financing transactions 85,271 89,648 84,245
Cash collateral receivables on derivative instruments 30,846 39,545 23,289
Loans and advances to customers 344,652 337,551 326,786
Other financial assets measured at amortized cost 27,253 23,765 22,980
Total financial assets measured at amortized cost 653,205 646,739 576,815
Financial assets at fair value held for trading 98,046 90,490 127,514
of which: assets pledged as collateral that may be sold or repledged by counterparties 38,505 31,192 41,285
Derivative financial instruments [1],[2],[3] 152,008 212,982 121,841
Brokerage receivables 19,848 20,319 18,007
Financial assets at fair value not held for trading 94,292 82,753 83,944
Total financial assets measured at fair value through profit or loss 364,194 406,544 351,307
Financial assets measured at fair value through other comprehensive income 8,624 7,653 6,345
Investments in associates 1,054 1,042 1,051
Property, equipment and software 12,875 12,764 12,804
Goodwill and intangible assets 6,414 6,407 6,469
Deferred tax assets 9,294 9,316 9,537
Other non-financial assets 8,177 7,634 7,856
Total assets 1,063,838 1,098,099 972,183
Liabilities      
Amounts due to banks 12,410 18,822 6,570
Payables from securities financing transactions 12,019 12,867 7,778
Cash collateral payables on derivative instruments 36,882 45,649 31,415
Customer deposits 474,254 465,946 448,284
Debt issued measured at amortized cost [4] 126,744 115,432 110,497
Other financial liabilities measured at amortized cost 9,699 9,934 9,712
Total financial liabilities measured at amortized cost 672,007 668,649 614,256
Financial liabilities at fair value held for trading 34,426 32,571 30,591
Derivative financial instruments [1],[2],[3] 152,280 206,649 120,880
Brokerage payables designated at fair value 40,248 37,652 37,233
Debt issued designated at fair value 58,864 53,299 66,809
Other financial liabilities designated at fair value 37,902 31,536 35,940
Total financial liabilities measured at fair value through profit or loss 323,721 361,707 291,452
Provisions 2,601 2,566 2,974
Other non-financial liabilities 8,302 7,059 8,794
Total liabilities 1,006,630 1,039,981 917,476
Equity      
Share capital 338 338 338
Share premium 17,125 17,633 18,064
Treasury shares (3,592) (3,636) (3,326)
Retained earnings 35,991 36,796 34,154
Other comprehensive income recognized directly in equity, net of tax 7,173 6,818 5,303
Equity attributable to shareholders 57,035 57,949 54,533
Equity attributable to non-controlling interests 173 169 174
Total equity 57,207 58,118 54,707
Total liabilities and equity $ 1,063,838 $ 1,098,099 $ 972,183
[1]
Derivative financial liabilities as of 30 June 2020 include USD 35 million related to derivative loan commitments (31 March 2020: USD 43 million; 31 December 2019: USD 17 million). No notional amounts related to these commitments are included in this table, but they are disclosed in Note 17, under Loan commitments
[2]
Financial assets and liabilities are presented net on the balance sheet if UBS has the unconditional and legally enforceable right to offset the recognized amounts, both in the normal course of business and in the event of default, bankruptcy or insolvency of UBS or its counterparties, and intends either to settle on a net basis or to realize the asset and settle the liability simultaneously
[3]
Includes certain forward starting repurchase and reverse repurchase agreements that are classified as measured at fair value through profit or loss and are recognized within derivative instruments. The fair value of these derivative instruments was not material for any periods presented. No notional amounts related to these instruments are included in this table, but they are disclosed in Note 17, under Forward starting transactions.
[4]
Net of bifurcated embedded derivatives, the fair value of which was not material for the periods presented.